Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 1999

View Archived Issues

Urologix's Targis System superior to alpha-blockers in BPH therapy

ADCON-L improves clinical outcome following lumbar discectomy

Pacific Pharmaceuticals acquires Binary Therapeutics

DTaP-IPV vaccine receives marketing authorization in Germany

ID Biomedical and Ribi ImmunoChem to develop E. coli vaccine

RPR and Targacept enter agreement to develop AD and PD treatments

Sunrise LTK System PMA accepted for filing by FDA

ICAgen obtains patent and exclusive rights to ion channel technology

Platinum-based chemotherapy for ovarian cancer increases risk of leukemia

Bristol-Myers Squibb and EntreMed modify research agreement

Roberts enriches product pipeline with addition of RL-0903

Patient enrollment completed in loteprednol/antibiotic combination study

Shaman changes direction; new focus is on botanicals

OT-7100, a novel analgesic compound for the treatment of peripheral neuropathic pain

Potassium channel modulators claimed for dementia by Bayer

New polycarboxamides with multiple pharmacological actions developed at Pharmacia & Upjohn

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Antiinflammatory/immunosuppressant agents acting on p38 MAP kinase designed at Novartis

TNP-470 inhibits human lung tumor growth and neovascularization

Isotechnika's novel atomic substitution technology yields improved calcium channel blocker

Renal toxicity of NS-718 and amphotericin B compared in laboratory and animal studies

Aronex further defines mechanism of action of AR-177

In vitro and in vivo profile of antifungal activity reported for FK-463

BCH-10652: structure and first clinical data presented at AIDS conference

Facilitated DNA plasmid vaccine construct induces immune responses in HIV+ subjects

Genentech to withdraw support from pimagedine development

Sarawak MediChem's calanolide compounds featured at ROI conference

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...